Skip to content

Gestational Diabetes Mellitus and Implications for Cardiovascular Disease Risk

Gestational Diabetes Mellitus and Implications for Cardiovascular Disease Risk

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00550979
Enrollment
96
Registered
2007-10-30
Start date
2007-09-30
Completion date
2014-01-31
Last updated
2013-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes Mellitus

Keywords

gestational diabetes mellitus, cardiovascular disease risk, heart disease risk

Brief summary

The purpose of this research study is to look at whether there are differences in blood vessel function, risk for developing diabetes (high blood sugar), lipid (blood fat) levels, and levels of other blood markers in women who have had a pregnancy complicated by diabetes as compared with women who have had a normal pregnancy.

Interventions

None listed

Sponsors

Massachusetts General Hospital
CollaboratorOTHER
Joslin Diabetes Center
CollaboratorOTHER
Brigham and Women's Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy women of self-identified African descent (black) and European (white) ancestry * 18-40 years of age * Regular menstrual cycles * 5 or less years postpartum * Have either a normal or a GDM index pregnancy history * Are in good health free of thyroid, cardiac, or renal disease

Exclusion criteria

* If you are pregnant * If you are lactating

Design outcomes

Primary

MeasureTime frame
endothelial functionsame day

Countries

United States

Contacts

Primary ContactResearch Assistant
RBLResearchGroup@partners.org617-724-3504
Backup ContactRhonda Bentley-Lewis, MD, MBA
rbentleylewis@partners.org617-726-2874

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026